Benefits
Improved sleep quality and reduced insomnia severity
Participants taking 485 mg DailyZz before bed reported improved sleep quality and reduced Insomnia Severity Index scores vs control. The dual sleep quality + insomnia severity improvement supports comprehensive sleep applications, addressing both subjective sleep experience and clinical insomnia indicators.
5× daytime focus improvement
DailyZz improved daytime focus by 5x while improving working memory by 60%. Distinguishes DailyZz as a natural sleep nootropic shown to benefit users post-sleep, addressing the downstream impact of sleep on daytime cognition.
60% working memory improvement
DailyZz produced a 60% improvement in working memory alongside focus enhancement. Working memory is the ability to hold and manipulate information short-term, critical for problem-solving, learning, and decision-making. The cognitive benefits represent meaningful improvements in daytime cognitive performance from sleep support.
Mental speed and decision-making support
DailyZz produced improvements in mental speed and decision-making alongside focus and working memory. The multi-domain cognitive improvement supports applications for professionals, students, and anyone whose daytime performance is impacted by sleep quality. Distinguishes DailyZz from sleep-only ingredients without daytime cognitive validation.
Fast 7-14 day onset
DailyZz significantly improves both sleep quality and next-day functioning in 7-14 days. The fast onset distinguishes it from many sleep supplements requiring 4-8 weeks for measurable effects. Practical for acute sleep concerns and seasonal sleep disruption.
100-participant comprehensive trial
Clinical testing in healthy participants with occasional sleep complaints demonstrated safety, efficacy, and tangible benefits of DailyZz, providing a robust evidence base.
GABA and acetylcholine modulation
DailyZz's polyphenols (rosmarinic acid and EGCG) reduce oxidative stress and modulate brain chemicals — including GABA (inhibitory neurotransmitter supporting sleep initiation) and acetylcholine (involved in REM sleep and cognitive processing). Modulating both neurotransmitter systems supports the dual sleep + cognitive applications.
Antioxidant neuroprotection
Rosmarinic acid and EGCG are well-characterized antioxidants with documented neuroprotective effects. Oxidative stress in the brain contributes to sleep disturbance, cognitive decline, and broader neurological concerns. Reducing oxidative stress supports both acute and long-term cognitive and sleep applications.
Mechanism of action
GABAergic sleep modulation
Spearmint rosmarinic acid and green tea EGCG modulate GABA (gamma-aminobutyric acid) — the primary inhibitory neurotransmitter and the target of pharmaceutical sleep aids (benzodiazepines, Z-drugs). Natural GABA modulation supports sleep without the dependence and side effect concerns of pharmaceutical alternatives.
Acetylcholine cognitive support
DailyZz polyphenols modulate acetylcholine — the neurotransmitter critical for REM sleep, memory, and cognitive processing. Acetylcholine activity supports the post-sleep cognitive benefits (focus, working memory, decision-making). Dual GABA + acetylcholine modulation is unusual — supports both sleep and wake-state cognition.
Polyphenol antioxidant activity
Rosmarinic acid and EGCG are well-characterized polyphenolic antioxidants. Brain tissue is particularly vulnerable to oxidative damage due to high metabolic activity. Reducing oxidative stress supports neural health, sleep quality, and cognitive function across the lifespan.
Neuroprotective effects
Both rosmarinic acid and EGCG have documented neuroprotective effects in preclinical research — protecting neurons from various insults including oxidative stress, excitotoxicity, and inflammation. Mechanism supports long-term cognitive applications beyond acute sleep and next-day performance effects.
Water extraction selectivity
DailyZz uses gentle water extraction of certified sustainably grown spearmint and green tea. Water extraction preserves heat-sensitive polyphenols while leaving behind lipophilic compounds — supporting the specific polyphenolic standardization. Clean-label extraction supports consumer-facing applications.
Clinical trials
Randomized double-blind placebo-controlled clinical trial evaluating DailyZz at 485 mg/day 30 minutes before bed in 100 healthy participants with occasional sleep complaints. 30-day intervention. Conducted at University of Arizona Sleep and Health Research Programme by Dr. Michael Grandner. Published in International Journal of Environmental Research and Public Health (Tubbs, Kennedy, Alfonso-Miller, Wills, Grandner).
100 healthy adults with occasional sleep complaints. 30-day intervention with DailyZz or placebo.
Improved sleep quality and reduced Insomnia Severity Index scores in the DailyZz group vs placebo. Improvements in concentration, judgment, and post-sleep cognitive performance. 5× improvement in daytime focus and 60% improvement in working memory. Mental speed and decision-making improvements. Established DailyZz as the first natural sleep nootropic with post-sleep cognitive validation.
Internal Kemin Technical Document TD-19-6000: randomized double-blind placebo-controlled study assessing effects of proprietary spearmint extract blend on sleep in healthy men and women. Foundation for the published trial. Kemin internal study with sleep parameters as primary outcomes.
Healthy men and women — adults with occasional sleep complaints.
Foundational evidence for DailyZz's sleep and cognitive benefits. Spearmint extract blend with green tea showed sleep quality improvements and cognitive benefits. Kemin internal trial preceded and informed the published University of Arizona research. Established 485 mg dose 30 minutes before bed as effective intervention.
Class evidence supporting rosmarinic acid and EGCG sleep and cognitive mechanisms. Both compounds have documented neurological and antioxidant effects in extensive preclinical and clinical research base.
Various — preclinical and clinical research on rosmarinic acid and EGCG.
Both compounds have documented effects on GABA neurotransmission, acetylcholine modulation, antioxidant activity, and neuroprotection. The mechanistic foundation supports DailyZz's clinical effects. Combined polyphenolic blend provides multi-mechanism support vs single-compound interventions.